REYVOW Trademark

Trademark Overview

On Thursday, May 11, 2017, a trademark application was filed for REYVOW with the United States Patent and Trademark Office. The USPTO has given the REYVOW trademark a serial number of 87446502. The federal status of this trademark filing is REGISTERED as of Tuesday, March 31, 2020. This trademark is owned by Eli Lilly and Company. The REYVOW trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of migraines and pain
reyvow

General Information

Serial Number87446502
Word MarkREYVOW
Filing DateThursday, May 11, 2017
Status700 - REGISTERED
Status DateTuesday, March 31, 2020
Registration Number6024518
Registration DateTuesday, March 31, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of migraines and pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 16, 2017
Primary Code005
First Use Anywhere DateMonday, February 3, 2020
First Use In Commerce DateMonday, February 3, 2020

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Tuesday, March 31, 2020REGISTERED-PRINCIPAL REGISTER
Friday, February 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 18, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, February 7, 2020USE AMENDMENT FILED
Friday, February 7, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, October 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 14, 2019EXTENSION 4 GRANTED
Monday, October 14, 2019EXTENSION 4 FILED
Monday, October 14, 2019TEAS EXTENSION RECEIVED
Wednesday, April 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2019EXTENSION 3 GRANTED
Monday, April 8, 2019EXTENSION 3 FILED
Monday, April 8, 2019TEAS EXTENSION RECEIVED
Friday, October 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 17, 2018EXTENSION 2 GRANTED
Wednesday, October 17, 2018EXTENSION 2 FILED
Wednesday, October 17, 2018TEAS EXTENSION RECEIVED
Thursday, May 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 16, 2018EXTENSION 1 GRANTED
Tuesday, May 1, 2018EXTENSION 1 FILED
Wednesday, May 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 1, 2018TEAS EXTENSION RECEIVED
Tuesday, November 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 15, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

reyvow pharmaceutical preparations pain migraines namely treatment